Allison Morgan

Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study

Thomas Voit, Haluk Topaloğlu, Volker Straub et al. · The Lancet Neurology · 2014 · 293 citations

Placebo-controlled Phase 2, Medicine, Duchenne Muscular Dystrophy +5

Understanding the under representation of women in IT

Eileen M. Trauth, Jeria L. Quesenberry, Allison Morgan · 2004 · 114 citations

Feminist Philosophy, Gender Disparity, Appropriate Theory +14

Power relations in IT education and work: the intersectionality of gender, race, and class

Lynette Kvasny, Eileen M. Trauth, Allison Morgan · Journal of Information Communication and Ethics in Society · 2009 · 88 citations

Gendered Perception, Education, Power Relation +26

Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: Results of a double-blind randomized clinical trial

Kevin M. Flanigan, Thomas Voït, Xiomara Q. Rosales et al. · Neuromuscular Disorders · 2013 · 69 citations · Full text

Pharmacotherapy, Pre-clinical Pharmacology, Drisapersen Treatment +16

Understanding the "Mommy Tracks"

Jeria L. Quesenberry, Eileen M. Trauth, Allison Morgan · Information Resources Management Journal · 2006 · 62 citations · Full text

Music, Parental Care, It Workforce +21